Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply

Affiliations

• ¹ Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
• ² Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK & Newcastle NIHR Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.
• ³ John Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
• ⁴ Department of Internal Medicine, Medical College of Virginia, Richmond, Virginia, USA.
• ⁵ Swedish Medical Group, Seattle, Washington, USA.
• ⁶ Division of Gastroenterology and Hepatology, Department of Medicine, Saint Louis University, Saint Louis, Missouri, USA.
• ⁷ Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University, Indianapolis, Indiana, USA.
• ⁸ Division of Gastroenterology, Hepatology, and Nutrition, Duke University, Durham, North Carolina, USA.
• ⁹ Division of Gastroenterology and Liver, Keck Medicine, University of Southern California, Los Angeles, California, USA.
• ¹⁰ Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA.
• ¹¹ NAFLD Research Center, Department of Medicine, University of California San Diego, San Diego, California, USA.
• ¹² Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
• ¹³ Analytic Pathology Medical Group, Sharp Memorial Hospital, San Diego, California, USA.